PortViewPortView
Aspire Biopharma logo

Aspire Biopharma (ASBP) Stock Analysis

NASDAQHealthcareBiotechnology

$8.92+0.11%
1-year price historyRange $4.65 – $703.20
52-week range$8.92
$0.11$23.48

What Aspire Biopharma does

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Key metrics

Market cap
$1.03M
P/E (TTM)
-0.37
EPS (TTM)
$-23.80
Beta
0.15
Dividend yield
0.00%
Revenue / share
$0.09
50-day avg
$7.00
200-day avg
$3.87
52-week high
$23.48
52-week low
$0.11
CEO
Kraig T. Higginson

ETFs linked to ASBP

Broad-market and Healthcare sector ETFs an investor holding Aspire Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ASBP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ASBP in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Aspire Biopharma?
Aspire Biopharma trades under the ticker ASBP on NASDAQ.
Which exchange is ASBP listed on?
ASBP is listed on NASDAQ.
What sector does Aspire Biopharma operate in?
Aspire Biopharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ASBP in a portfolio?
PortView shows ASBP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.